Abstract
In 1883, Sidney Ringer described the importance of calcium in cardiac contraction (Ringer, 1883). Since that seminal observation, the importance of calcium as a transducer for coupling of biological signals has become evident. The signal transduction role of calcium is made possible by a large, inward-directed gradient of ionized calcium across the plasma membrane. Cytosolic concentrations of calcium in a resting, nonstimulated cell are some 10,000-fold lower than external concentrations (approximately 10−7 M vs 10−3 M) (Fozzard et al., 1985; Tsien et al., 1984). This extreme gradient is maintained by an intrinsic low permeability of the plasma membrane to calcium, active exchange mechanisms and pumps that remove calcium, sequestration of calcium by intracellular organelles such as mitochondria and the endoplasmic reticulum, and buffering by cytosolic calcium-binding proteins. Elevation of cytosolic calcium contractions to 1–10 μM initiates physiologic responses appropriate to the cell type. In muscle, interaction with troponin C or other calcium-binding regulatory proteins initiates contraction. In neuronal, exocrine, and endocrine tissue, secretion ensues. The diversity of responses initiated, the energy expenditure to maintain low cytosolic levels, and the multiplicity of ways to deplete cytosolic calcium all highlight the biologic importance of this messenger system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen, G.S., Ahn, H.S.,Preziosi, T.J., Battye, R., Boone, S.C., Chou, S.N., Kelly, D.L., Weir, B.K., Crabbe, R.A., Lavik, P.J., Rosenbloom, S.B., Dorsey, F.C., Ingram, C.R., Mellits, D.E., Bertsh, L. A., Boisvert, D.P.J., Hundley, M.B., Johnson, R.K., Strom, J.A. and Transou, C.R.(1983) Cerebral anterial spasm. A controlled trial of nimodipine in patients with subarachonoid hemorrahge. N. Eng. J. Med. 308, 619–624.
Bartoletti, M. and Labo, G. (1981) Clinical and manometric effects of nifedipine in patients with esophageal achalasia. Gastroenterology 83, 963–969.
Bayer, R. Kaufmann, R., and Mannhold, R. (1975) Inotropic and electrophysiological actions of verapamil and D600 in mammalian myocardium. Naunyn Schmiedebergs Arch. Pharmacol. 290, 69–80.
Bellemann, P., Ferry, D., Lubbecke, F., and Glossmann, H. (1981) [3H]- Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. Arzneimittelforsch. 31. 2064–2067.
Berridge, M. J. and Irvine, R. F. (1984) Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312, 315–321.
Bolger, G. T., Gengo, P., Klockowski, R., Luchowski, E., Siegl, H., Janis, R. A., Triggle, A. M., and Triggle, D. J. (1983) Characterization of binding of the Ca2+,-channel antagonist, [3H]-nitrendipine, to guinea pig ileal smooth muscle. J. Phantiacol. Exp. Ther. 225, 291–310.
Bolger, G. T., Weissman, B. A., and Skolnick, P. (1985) The behavioral effects of the calcium agonist BAY K 8644 in the mouse: Antagonism by the calcium antagonist nifedipine. Naunyn Schmiedebergs Arch. Pharmacol. 328, 373–377.
Bolton, T. B. (1979) Mechanism of action of transmitters and other substances on smooth muscle. Physiol. Rev. 59, 606–718.
Bristow, M. R., McAuley, B., Ginsburg, R., Minobe, W. A., and Baisch, M. (1982) Does [3H] nitrendipine bind to sarcolemmal slow channels? Circulation 66 (II), 95.
Burgess, G. M., Godfrey, P. P., McKinney, J. S., Berridge, M.J., Irvine, R. F., and Putney, Jr., J. W. (1984) The second messenger linking receptor activation to internal Ca release in liver. Nature (Lond.) 309, 63–66.
Cauvin, C., Loutzinhiser, R., and Van Breemen, C. (1983) Mechanisms of calcium antagonist-induced vasodilation. Ann. Rev. Pharmacol. Toxicol. 23, 373–396.
Cerrina, J., Denjean, A., Alexandre, G., Lockhard, A., and Duroux, P. (1981) Inhibition of exercise-induced asthma by a calcium antagonist nifedipine. Am. Rev. Respir. Dis. 123, 156–160.
Cortes, R., Supavilai, P., Karobath, M., and Palacios, J. M. (1983) The effects of lesions in the rat hippocampus suggest the association of calcium channel blocker binding sites with specific neuronal population. Neurosci. Lett. 42, 249–254.
Crow, T. J. (1980) Molecular biology of schizophrenia: More than one disease process? Br. Med. J. 280, 66–67.
Dangman, K. H. and Hoffman, B. F. (1980) Effects of nifedipine on electrical activity of cardiac cells. Am. J. Cardiol. 46. 1059–1067.
Denef, D., Van Neuten, J. M., Leysen, J. E., and Janssen, P. A. J. (1979) Evidence that pimozide is not a partial agonist of dopamine receptors. Life Sci. 25, 217–225.
DePover, A., Matlib, M. A., Lee, S. W., Dupe. G. P., Grupp, I. L., Grupp, G., and Schwartz, A. (1982) Specific binding of [3H)-nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem. Biochem. Biophys. Res. Commun. 108, 112–117.
DePover, A., Lee, S. W„ Matlib, M. A., Whitmer, K., Davis, B. A., Powell, T., and Schwartz, A. (1983) [3H]-Nimodipine specific binding to cardiac myocytes and subcellular fractions. Biochem. Biophys. Res. Commun. 113, 185–191.
Ehara, T. and Daufmann, R. (1978) The voltage- and time-dependent effects of (-)-verapamil on the slow inward current in isolated cat ventricular myocardium. J. Pharmacol. Exp. Ther. 207. 49–55.
Ehlert, F. J., Roeske, W. R., Itoga, E„ and Yamamura, H. I. (1982) The binding of [3H]-nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats. Life Sci. 30, 2191–2202.
Eigenmann, R., Blaber, L., Nakamura, K., Thorens, S., and Haeusler, G. (1981) Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies. Arzneimittelforsch. 31, 1393–1401.
Emanuel, M. B. (1979) Specific calcium antagonists in the treatment of peripheral vascular disease. Angiology 30, 454–469.
Fairhurst, A. S., Thayer, S. A., Colker, J. E., and Beatty, D. A. (1983) A calcium antagonist drug binding site in skeletal muscle sarcoplasmic reticulum: Evidence for a calcium channel. Life Sci. 32, 1331 - 1339.
Ferry, D. R. and Glossmann, H. (1982) Evidence for multiple receptor sites within the putative calcium channel. Naunyn Schmiedebergs Arch. Pharmacol. 321, 80–83.
Ferry, D. R., Goll, A., and Glossmann, H. (1983) Differential labelling of putative skeletal muscle calcium channels by [3H]nifedipine, (3H)nimodipine and (3H)PN 200 110. Naunyn Schmiedebergs Arch. Pharmacol. 323, 276–277.
Fleckenstein, A. (1971) Specific Inhibitors and Promoters of Calcium Action in the Excitation-Contraction Coupling of Heart Muscle and Their Role in the Prevention or Production of Myocardial Lesions, in Calcium and the Heart ( Harris, P. and Opie, L., eds.) Academic, New York.
Fleckenstein, A. (1977) Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Ann. Rev. Pharmacol. Toxicol. 17, 149–166.
Fleckenstein, A. (1981) Fundamental Actions of Calcium Antagonists on Myocardial and Cardiac Pacemaker Cell Membranes, in New Perspectives on Calcium Antagonists ( Weiss, G. B., ed.) American Physiological Society, Bethesda, Maryland.
Fleckenstein, A. (1983) Calcium Antagonism in Heart and Smooth Muscle, Wiley-Interscience, New York.
Fleckenstein, A. (1984) Calcium Antagonism: History and Prospects for a Multifaceted Pharmacodynamic Principle, in Calcium Antagonists and Cardiovascular Disease ( Opie, L. H., ed.) Raven, New York.
Fleckenstein, A. and Grun, G. (1969) Reversible blockade of excitation- contraction coupling in rat’s uterine smooth muscle by means of organic calcium antagonists (Iproveratril, D600, prenylamine). Pflugers Arch. Physiol. 307, R26.
Fleckenstein, A., Tritthart, H., Fleckenstein, B., Herbst, A., and Grun, G. (1969) A new group of competitive Ca antagonists (Iproveratril, D600, prenylamine) with highly potent inhibitory effects on excitation-contraction coupling in mammalian myocardium. Pflugers Arch. 391, R12.
Forman, A., Andersson, K.-E., and Ulmsten, U. (1981) Inhibition of myo-metrial activity by calcium antagonists. Seminars in Perinatology 5, 288–294.
Fossett, M., Jaimovich, E., Delpont, E., and Lazdunski, M. (1983) (3H]Nitrendipine receptors in skeletal muscle. Properties and preferential localization in transverse tubules. J. Biol. Chem. 258, 6086 - 6092.
Fozzard, H. A., Chapman, R. A., and Friedlander, I. R. (1985) Measurement of intracellular calcium ion activity with neutral exchanger ion sensitive microelectrodes. Cell Calcium 6, 57–68.
Frangos, II., Zissis, N. P., Leontopoulos, I., Diamantas, N., Tsitouridis, S., Gavril, I., and Tsolis, K. (1978) Double-blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics. Acta Psychiatr. Scand. 57, 436–446.
Freedman, S. B. and Miller. R. J. (1984) Calcium channel activation: A different type of drug action. Proc. Natl. Acad. Sci. USA 81, 5580–5583.
Freedman, S. B., Dawson, G., Villereal, M. L., and Miller, R. J. (1984a) Identification and characterization of voltage sensitive calcium channels in neuronal clonal cell lines. J. Neurosci. 4, 1453–1467.
Freedman, S. B., Miller, R.J., Miller, D. M„ and Tindall, D. R. (1984b) Interactions of maitotoxin with voltage-sensitive calcium channels in cultured neuronal cells. Proc. Natl. Acad. Sci. USA 81, 4582 - 4585.
Galizzi, J. P., Fosset, M. and Lazdunski, M. (1984a) [3H] Verapamil binding sites in skeletal muscle transverse tubule membranes. Biochem. Biophys. Res. Commun. 118, 239–245.
Galizzi, J. P., Fosset, M., and Lazdunski, M. (1984b) Properties of receptors for the Ca2+ channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Eur. J. Biochem. 144, 211–215.
Garcia, M. L.., Trumble, M.J., Reuben, J. P., and Kaczorowski, G. J. (1984) Characterization of verapamil binding sites in cardiac membrane vesicles. J. Biol. Chem. 259, 15013–15016.
Garcia, M. L., King, V. F., and Kaczorowski, G. (1985) Interaction of diltiazem binding sites with dihydropyridine and verapamil receptors in cardiac sarcolemmal membrane vesicles. Fed. Proc. 44, 715.
Gelmers, H. J. (1983) Nimodipine, a new calcium antagonist, in the prophylactic treatment of migraine. Headache 23, 106–109.
Glossmann, H. and Ferry, D. R. (1983) Molecular Approach to the Calcium Channel, in New Calcium Antagonists ( Fleckenstein, A., Hashimoto, K., Herrmann, M., Schwartz, A., and Seipel, L., eds.) Gustav Fischer Verlag, New York.
Glossmann, H., Ferry, D. R., Lubbecke, F., Mewes, R., and Hofmann, F. (1982) Calcium channels: Direct identification with radioligand binding studies. Trends Pharmacol. Sci. 3, 431–437.
Glossmann, H., Linn, T., Rombusch, M., and Ferry, D. R. (1983) Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists. FEBS Lett. 160, 226–232.
Goetz, C. G., Carvey, P. M., Tanner, C. M., and Klawans, H. L. (1984) Neuroleptic-induced dopamine hyposensitivity. Life Sci. 34, 1475– 1479.
Gould, R. J., Murphy, K. M. M., and Snyder, S. H. (1982a) Autoradiographic visualization of [3H]nitrendipine binding sites in rat brain: Localization to synaptic zones. Eur. J. Pharmacol. 81. 517–519.
Gould, R. J., Murphy, K. M. M. and Snyder, S. H. (1982b) [3H]Nitrendipine-labelled calcium channels discriminate inorganic calcium agonists and antagonists. Proc. Natl. Acad. Sci. USA 79, 3656–3660.
Gould, R. J., Murphy, K. M. M., and Snyder, S. H. (1983a) Studies on voltage-operated calcium channels using radioligands. Cold Spring Harbor Sump. Quant. Biol. 48, 355–362.
Gould, R. J., Murphy, K. M. M., Reynold, I. J., and Snyder, S. H. (1983b) Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. Proc. Natl. Acad. Sci. USA 80, 5122–5125.
Gould, R. J., Murphy, K. M. M., and Snyder, S. H. (1984a) Tissue heterogeneity of calcium channel antagonist binding sites labelled by [3H]nitrendipine. Mol. Pharmacol. 25, 235–241.
Gould, R. J., Murphy, K. M. M., Reynolds, I. J., and Snyder, S. H. (1984b) Calcium channel blockade: Possible explanation for thioridazine’s peripheral side effects. Am. J. Psych. 141, 352–357.
Gould, R. J., Murphy, K. M. M., and Snyder, S. H. (1985) Autoradiographic localization of calcium channel antagonist receptors in rat brain with [3H]nitrendipine. Brain Res. 330, 217–223.
Green, F.J., Farmer, B. B., Wiseman, G. L., Jose, M. J. L., and Watanabe, A. M. (1985) Effect of membrane depolarization on binding of 3H- nitrendipine to rat myocytes. Circ. Res. 56, 576–585.
Grover, A. K., Kwan, C. Y., Luchowski, E.E., Daniel, E. E., and Triggle, D. J. (1984) Subcellular distribution of [3H]nitrendipine binding in smooth muscle. J. Biol. Chem. 259, 2223–2226.
Haas, S. and Beckmann, H. (1982) Pimozide versus halopcridol in acute schizophrenia. A double blind controlled study. Pharmacopsychiatria 15, 70–74.
Haas, H. and Hartfelder, G. (1962) α-Isopropyl-α-(N-methyl- homoveratryl)-γ-aminopropyl-3,4-dimethoxy-phenylacetonitril, eine Substanz mit Coronargefasserweiternden Eigenschaften. Arzneimittelforsch. 12, 549–558.
Henry, P. D. (1980) Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem. Am. J. Cardiol. 46, 1047 - 1058.
Hess, P., Lansman, J. B., and Tsien, R. W. (1985) A novel type of cardiac calcium channel in ventricular cells. Nature (Lond.) 316, 443–446.
Hoffmeister, F., Benz, U., Heise, H., Krause, P., and Neuser, V. (1982) Behavioral effects of nimodipine in animals. Arzneimitelforsch. 32, 347–360.
Holck, M., Thorens, S., and Haeusler, G. (1982) Characterization of [3H] nifedipine binding sites in rabbit myocardium. Eur. J. Phannacol. 85, 305–315.
Hulthen, U. L., Landmann, R., Burgisser, E., and Buhler, F. R. (1982) High-affinity binding sites for [3H] verapamil in cardiac membranes. J. Cardiovasc. Pharmacol. 4, S291–S93.
Janis, R. A. and Triggle, D. J. (1983) New developments in Ca2+ channel antagonists. J. Med. Chem. 26, 775–785.
Janis, R. A., Maurer, S. C., Sarmiento, J. G., Bolger, G. T., and Triggle, D. J. (1982) Binding of [3H] nimodipine to cardiac and smooth muscle membranes. Eur. J. Pharmacol. 82. 191–194.
Janis, R. A., Rampe, D„ Sarmiento, J. G., and Triggle, D. J. (1984a) Specific binding of a calcium channel activator, (3H] Bay K 8644, to membranes from cardiac muscle and brain. Biochem. Biophys. Res. Comm. 121, 317–323.
Janis, R. A., Sarmiento, J. G., Maurer, S. C., Bolger, G. T.. and Triggle, D. J. (1984b) Characteristics of the binding of [3H] nitrendipine to rabbit ventricular membranes: Modification by other Ca2+ channel- antagonists and the Ca2+ channel antagonist Bav K 8644. J. Pharmacol. Exp. Ther. 221, 8–15.
Kaczorowski, G., King, V. F., and Garcia, M. L. (1985) Characterization of diltiazem binding sites in cardiac sarcolemmal membrane vesicles. Fed. Proc. 44, 169–192. 715.
Kambara, H., Fujimoto, K., Wakabayashi, A., and Kawai, C. (1981) Primary pulmonary hypertension: Beneficial therapv with diltiazem. Am. Heart J. 101, 230–231.
Kaplita, P. V. and Triggle, D. J. (1983) Actions of Ca2+ antagonists on the guinea-pig ileal myenteric plexus preparation. Biochem. Pharmacol. 32, 65–68.
Karaki, H. and Weiss, G. B. (1984) Calcium channels in smooth muscle. Gastroenterology 87, 960–970.
Kass, R. S. and Tsien, R. W. (1975) Multiple effects of calcium antagonists on plateau currents in cardiac Purkinje fibers. J. Gen. Physiol. 66, 169–192.
Kohlhardt, M., Bauer, B., Krause, H., and Fleckenstein, A. (1972) Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibers by the use of specific inhibitors. Pflugers Arch. 335, 309–322.
Kuroda, Y., Yoshii, M., Tsunoo, A., Yasumoto, T., and Narahashi, T. (1984) Recording of calcium current in gigaohm scaled neuroblastoma cells and the mechanism of action of maitotoxin. Neurochem. Res. 9, 1172.
Landmark, K., Sire, S., Thaulow, E., Amlie, J. P., and Nitter-Hauge, S. (1982) Hemodynamic effects of nifedipine and propranolol in patients with hvpertropic obstructive cardiomyopathy, Br. Heart J. 48, 19–26.
Lapierre, Y. D. (1978) A controlled study of penfluridol in the treatment of chronic schizophrenia. Am. J. Psychiatry 135, 956–959.
Lee, K. S. and Tsien, R. W. (1983) Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialyzed heart cells. Nature (Lond.) 302, 790–794.
Lindner, E. (1960) Phenyl-propyl-diphenyl-propyl-amin, eine neue Substanz mit coronargefasserweiternder Wirkung. Arzneimittelforsch. 10, 569–573.
MacLeod, R. M. and Lamberts, S. W. J. (1978) The biphasic regulation of prolactin secretion by dopamine agonists-antagonists. Endocrinology 103, 200–203.
Mannhold, R., Zierden, P., Bayer, R., Rodenkirchen, R., and Steiner, R. (1981) The influence of aromatic substitution on the negative inotropic action of verapamil in the isolated cat papillary muscle. Arzneimittelforsch. 31, 773–780.
Marangos, P. J., Patel, J., Miller, C., and Martino, A. M. (1982) Specific calcium antagonist binding in brain. Life Sci. 31, 1575–1585.
Marsh, J. D„ Loh, E., LaChance, D., Barry, W. H., and Smith, T. W. (1983) Relationship of binding of a calcium channel blocker to inhibition of contraction in intact cultured embryonic chick ventricular cells. Circ. Res. 53, 539–543.
Metzger, H., Stern, H. O., Pfitzer, G., and Ruegg. J. C. (1982) Calcium antagonists affect calmodulin-dependent contractility of a skinned smooth muscle. Arzneimittelforsch 32, 1425–1427.
Middlemiss, D. N. and Spedding. M. (1985) A functional correlate for the dihvdropyridine binding site in rat brain. Nature (Lond.) 314, 94–96.
Miller, R. J. and Freedman. S. B. (1984) Are dihydropyridine binding sites voltage sensitive calcium channels? Life Sci. 34. 1205–1221.
Miller, W. C. and Moore, J. B. (1983) [3H)Nitrendipine binding in uterine smooth muscle. Phannacologist 25, 520.
Miller, D. M., Davin, W. T., and Tindall, D. R. (1985) Effects of maitotoxin on guinea pig ileum contraction partially ameliorated by calcium channel antagonists. Toxicon 23, 34.
Murphy, K. M. M. and Snyder, S. H. (1982) Calcium antagonist receptor binding sites labeled with [3H]nitrendipine. Eur. J. Pharmacol. 77, 201–202.
Murphy, K. M. M., Gould, R. J., Largent, B. L., and Snyder, S. H. (1983) A unitarv mechanism of calcium antagonist drug action. Proc. Natl. Acad. Sci. USA 80, 860–864.
Murphy, K. M. M., Gould, R. J., and Snyder, S. H. (1984) Regulation of [3H) Nitrendipine Binding: A Single Allosteric Site for Verapamil, Diltiazem and Prenylamine, in Nitrendipine ( Scriabine, A., Vanov,S., and Deck, K., eds.) Urban and Schwarzenberg, Baltimore, Maryland.
Nagao, T., Sato, M., Iwasawa, Y., Takada, T., Ishida, R., Nakajima, H„ and Kiyomoto, A. (1972) Studies on a new 1,5-benzothiazepine derivative (CRD-401). III. Effects of optical isomers of CRD-401 on smooth muscle and other pharmacological properties. Jap. J. Pharmacol. 22, 467–478.
Nagao, T., Ikeo, T., and Sato, M. (1977) Influence of calcium ions on responses to diltiazem in coronary arteries. Jap. J. Pharmacol. 27, 330–332.
Nakajima, H., Hoshivama, M., Yamashita, K., and Kiyomoto, A. (1975) Effect of diltiazem on electrical and mechanical activity of isolated cardiac ventricular muscle of guinea pig. Jap. J. Pharmacol. 25, 383–392.
Narducci, F., Bassotti, G., Gaburri, M., Farroni, F., and Morelli, A. (1985) Nifedipine reduces the colonic motor response to eating in patients with the irritable colon syndrome. Am. J. Gastroenterol. 80, 317–319.
Nowycky, M. C., Fox, A. P., and Tsien, R. W. (1985) Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature (Lond.) 316, 440–443.
Ohizumi, Y., Kajiwara, A., and Yasumoto, T. (1983) Excitatory effect of the most potent marine toxin, maitotoxin, on the guinea pig vas deferens. J. Pharmacol. Exp. Ther. 227, 199–204.
Pan, M., Janis, R. A., and Triggle, D. J. (1983) Comparison of the equilibrium and kinetic binding characteristics of tritiated Ca2+channel inhibitors, nisoldipine, nitrendipine, and nifedipine.Pharmacologist 25,523.
Quirion, R. (1983) Autoradiographic localization of a calcium channel antagonist, [3H] nitrendipine, binding site in rat brain. Neurosci. Lett. 36, 267–271.
Quirion, R., Lafaille, F., and Nair, N. P. V. (1985) Comparative potencies of calcium channel antagonists and antischizophrenic drugs on central and peripheral calcium channel binding sites. J. Pharm. Pharmacol. 37, 437–440.
Reuter, H. (1967) The dependence of the slow inward current on external calcium concentration in Purkinje fibers. J. Physiol. (Lond.) 192, 479–492.
Reuter, H. (1968) Slow inactivation of currents in cardiac Purkinje fibers. J. Physiol. (Lond.) 197, 233–253.
Reynolds, I. J., Gould, R. J., and Snyder, S. H. (1983) [3H)Verapamil binding sites in brain and skeletal muscle: Regulation by calcium. Eur. J. Pharmacol. 95, 319–321.
Reynolds, I. J., Snowman, A. M„ and Snyder, S. H. (1985) [3H)Methoxy- verapamil ([3H]D-600) and [3H)desmethoxyverapamiI (([3H]D-888) label multiple receptors in brain and heart. Soc. Neurosci. Abstr. 11, 516.
Rezvani, A., Huidobro-Toro, J. P., and Way, E. L. (1983) Effect of 4-amino- pyridine and verapamil on the inhibitory action of normorphine on the guinea-pig ileum. Eur.J. Pharmacol. 86, 111–115.
Richter, J. E., Spurling, T. J., Cordova, C. M., and Castell, D. O. (1984) Effects of oral calcium blocker, diltiazem, on esophageal contraction: Studies in volunteers and patients with “nutcracker esophagus.” Dig. Dis. Sci. 29, 649–656.
Ringer, S. (1883) A further contribution regarding the influence of the different constituents of the blood on the contraction of the heart. J. Physiol. (Lond.) 4, 29–42.
Rodeheffer, R. J., Rommer, J. A., Wigley, F., and Smith, G. R. (1983) Controlled double-blind trial of nifedipine in the treatment of Raynaud’s phenomenon. N. Eng. J. Med. 308, 880–883.
Rosenberger, L. B. and Triggle, D. J. (1978) Calcium, Calcium Translocation and Specific Calcium Antagonists, in Calcium and Drug Action ( Weiss, G. B., ed.) Plenum, New York.
Rupniak, N. M. J., Jenner, P., and Marsden, C. D. (1983) The effect of chronic neuroleptic administration on cerebral dopamine receptor function. Life Sci. 32, 2289–2311.
Saida, K. and Van Breemen, C. (1982) Inhibiting effect of diltiazem on intracellular Ca2+ release in vascular smooth muscle. Blood Vessels 20, 105–108.
Saikawa, T., Nagamoto, Y., and Atrita, M. (1977) Electrophysiologic effects of diltiazem, a new slow channel inhibitor, on canine cardiac fibers, Jap. Heart J. 18, 235–245.
Sandahl, B., Ulmsten, U., and Anderssen, K. E. (1979) Trial of the calcium antagonist nifedipine in the treatment of primary dysmenorrhoea. Arch. Gynecol. 227, 147–151.
Sarmiento, J. G., Janis, R. A., Colvin, R. A., Maurer, S. C., and Triggle, D. J. (1982) Comparison of calcium channels in canine arterial and ventricular myocardium using [3H] nitrendipine binding. Fed. Proc. 41, 1707A.
Sarmiento, J. G., Janis, R. A., Colvin, R. A., Triggle, D. J., and Katz, A.M. (1983) Binding of the calcium channel blocker, nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle. J. Mol. Cell. Cardiol. 15, 135–137.
Sato, M., Nagao, T., Yamaguchi, I.„ Nakajima, H., and Kiyomoto, A. (1971) Pharmacological studies on a new 1,5-benzothiazepine derivative (CRD-401). I. Cardiovascular actions. Arzneimittelforsch 21, 1338–1343.
Schoemaker, 11, and Langer, S. Z. (1985) [3H)Diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex. Eur. J. Pharmacol. Ill, 273 - 277.
Schoemaker, H., Itoga. E., Boles, R. G., Roeske, W. R., Ehlert, F. W., Kito, S., and Yamamura, H. I. (1983) Temperature Dependence and Kinetics of [3H]Nitrendipine Binding in the Rat Brain, in Nitrendipine ( Scriabine, A., Vanov, S., and Deck, K., eds.) Urban and Schwarzenberg, Baltimore, Maryland.
Schramm, M., Thomas, G., Towart, R., and Frankowiak, G. (1983a) Activation of calcium channels by novel 1,4-dihydropyridines: A new mechanism for positive inotropics or smooth muscle stimulants. Arzneimittelforsch. 33, 1268–1272.
Schramm, M., Thomas, G., Towart, R., and Frankowiak, G. (1983b) Novel dihvdropyridines with positive inotropic action through activation of Ca2+ channels. Nature 303, 535–537.
Schumann, H. J., Gorlitz, B. D., and Wagner, J. (1975) Influence of papaverine, D600 and nifedipine on the effects of noradrenaline and calcium on the isolated aorta and mesenteric artery of the rabbit. Naunyn Schmiedebergs Arch. Pharmacol. 289, 409–418.
Schwartz, A. and Triggle, D. J. (1984) Cellular action of calcium channel blocking drugs. Ann. Rev. Med. 35, 325–339.
Scriabine, A., Vanov, S., and Deck, K., eds. (1984) Nitrendipine. Urban and Schwarzenberg, Baltimore, Maryland.
Schmizu, K., Ohta, T., and Noda, N. (1980) Evidence for greater susceptibility of isolated dog cerebral arteries to Ca antagonists than peripherial arteries. Stroke 11, 261–266.
Singh, B. N., Collett, J. T., and Chew, C. Y. (1980) New perspectives in the pharmacologic therapy of cardiac arrhythmias. Prog. Cardiovasc. Dis. 22, 243–301.
Singh, B. N., Nademanee, K., and Baky, S. H. (1983) Calcium antagonists. Clinical use in the treatment of arrhythmias. Drugs 25, 125–133.
Spedding, M. (1982) Assessment of “Ca2+-antagonist” effects of drugs in K+-depolarized smooth muscle. Differentiation of antagonist subgroups. Naunyn Schmiedebergs Arch. Pharmacol. 318, 234–240.
Spedding, M. and Berg, C. (1984) Interactions between a “calcium channel agonist,” Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle. Naunyn Schmiedebergs Arch. Phannacol. 328, 69–75.
Spivack, C., Ocken, S., and Frishman, W. H. (1983) Calcium antagonists. Clinical use in the treatment of systemic hypertension. Drugs 25, 154–177.
Starke, K., Spath, I,., and Wichmann, T. (1984) Effects of verapamil, diltiazem and ryosidine on the release of dopamine and acetylcholine in rabbit caudate nucclus slices. Naunyn Schmiedebergs Arch. Pharmacol. 325, 124–130.
Stone, P. H., Antman, E. M„ Muller, J. E„ and Braunwald, E. (1980) Calcium channel blacking agents in the treatment of cardiovascular disorders. II. Hemodynamic effects and clinical applications. Ann. Intern. Med. 93, 886–904.
Theroux, P., Taeymans, Y., and Waters, D. D. (1983) Calcium antagonists. Clinical use in the treatment of angina. Drugs 25, 178–195.
Thorgeirsson, G. and Rudolph, S. A. (1984) Diltiazem-like effect of thioridazine on the dihydropyridine binding sites of the calcium channel of rat myocardial membranes. Biochem. Biophys. Res. Commun. 121, 657–663.
Toll, L. (1982) Calcium antagonists. High-affinity binding and inhibition of calcium transport in a clonal cell line. J. Biol. Chem. 257, 13189–13192.
Triggle, D. J. and Janis, R. A. (1984) Calcium channel antagonists: New perspectives from the radioligand binding assay. Mod. Meth. Pharmacol. 2, 1–28.
Triggle, C. R., Agrawal, D. K., Bolger, G. T., Daniel, E. E., Kwan, C. Y., Luchowski, E. M., and Triggle, D. J. (1982) Calcium channel antagonist binding to isolated vascular smooth muscle membranes. Can. J. Physiol. Phartnacol. 60, 1738–1741.
Tsien, R. Y„ Pozzan, T., and Rink, T. J. (1984) Measuring and manipulating cytosolic Ca2+ with trapped indicators. Trends Biochem. Sci. 9, 263–266.
Turner, T. J. and Goldin, S. M. (1985) Calcium channels in rat brain synaptosomes: Identification and pharmacological characterization. High affinity blockade by organic Ca2+ channel blockers. J. Neurosci. 5, 841–849.
Ulmsten, U., Anderssen, K. E., and Wingerup, L. (1980) Treatment of premature labor with the calcium antagonist nifedipine. Arch. Gynecol. 229. 1–5.
Van Breeman, C. and Siegel, B. (1980) The mechanism of α-adrenergic activation of the dog coronary artery. Circ. Res. 46, 426–429.
Van Breemen, C., Hwang. O., and Meisheri, K. D. (1981) The mechanism of inhibitory action of diltiazem on vascular smooth muscle contractility. J. Pharmacol. Exp. Ther. 218, 459–463.
Vitek, M. and Trautwein, W. (1971) Slow inward current and action potential in cardiac Purkinje fibers. The effect of Mn ions. Pfleugers Arch. 323, 204–218.
Weiss, G. B., ed. (1981) New Perspectives on Calcium Antagonists, American Physiological Society, Bethesda, Maryland.
Williams, L. T. and Jones, L. R. (1983) Specific binding of the calcium antagonist, [3H] nitrendipine, to subcellular fractions isolated from canine myocardium—evidence for high affinity binding to ryanodine-sensitive sarcoplasmic reticulum. J. Biol. Chem. 258, 5344–5347.
Williams, L. T. and Tremble, P. (1982) Binding of a calcium antagonist, [3H] nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes. J. Clin. Invest. 70. 209–212.
Wit, A. L. and Ning, W. (1983) Effects of the Slow Channel Blockers Nifedipine and Verapamil on the Electrical Activity of the Sinoatrial and Atrioventricular Nodes, in Calcium Antagonists: The State of The Art and Role in Cardiovascular Disease. ( Hoffman, B. F., ed.) College of Physicians of Philadelphia, Philadelphia, Pennsylvania.
Yamamoto, H. and Van Breemen, C. (1985) Inositol 1,4,5-trisphosphate releases calcium from skinned, cultured smooth muscle cells. Bio- chem. Biophys. Res. Commun. 130, 270–274.
Yamamura, H. I., Schoemaker, H., Boles, R. G., and Roeske, W. R. (1982) Diltiazem enhancement of [3H] nitrendipine binding to calcium chan¬nel associated drug receptor sites in rat brain synaptosomes. Biochem. Biophys. Res. Commun. 108, 640–646.
Zelis, R. and Flaim, S. F. (1982) Calcium blocking drugs for angina pectoris. Ann. Rev. Med. 33, 465–478.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 The Humana Press Inc.
About this chapter
Cite this chapter
Gould, R.J. (1987). Calcium Channel Antagonists. In: Williams, M., Malick, J.B. (eds) Drug Discovery and Development. Humana Press. https://doi.org/10.1007/978-1-4612-4828-6_15
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4828-6_15
Publisher Name: Humana Press
Print ISBN: 978-1-4612-9180-0
Online ISBN: 978-1-4612-4828-6
eBook Packages: Springer Book Archive